Analyst Reco. Augmedix, Inc.

Equities

AUGX

US05105P1075

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
2.71 ^USD	-4.24%		-4.58%	-53.68%

Apr. 24	Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	CI
Apr. 12	Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing	Apr. 12	MT
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing	Apr. 05	MT
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing	Apr. 04	MT
Evercore ISI Adjusts Price Target on Augmedix to $4.50 From $6.50, Maintains In-Line Rating	Mar. 19	MT
Evercore ISI Initiates Augmedix With In Line Rating, Price Target is $6	Dec. 15	MT
Waning Optimism on Rate Hike Pause, Cisco Fall Pushes Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday	Nov. 16	MT
B. Riley Lifts Augmedix's PT to $7.50 From $6.50, Raises 2023 Outlook, Notes Increased Confidence in Business Trajectory; Maintains Buy Rating	Nov. 07	MT
B. Riley Lifts Augmedix's PT to $6.50 From $5.50 on Raised 2023 Outlook, Increased Confidence in Business Trajectory; Keeps Buy Rating	23-08-08	MT
B. Riley Lifts Augmedix's Price Target to $5.50 From $5 After Q1 Topline Beat, 'Strong' Q2 Guide; Keeps Buy Rating	23-05-15	MT
Benchmark Adjusts Price Target on Augmedix to $6 From $5, Maintains Buy Rating	23-04-21	MT
Maxim Group Adjusts Price Target on Augmedix to $8 From $5, Maintains Buy Rating	23-04-21	MT
B. Riley Lifts Augmedix's Price Target to $5 From $4 on Heels of Announced HCA Healthcare Partnership, Strategic Investment; Keeps Buy Rating	23-04-21	MT
Maxim Adjusts Price Target on Augmedix to $5 From $4, Maintains Buy Rating	23-03-28	MT
B. Riley Resumes Augmedix at Buy With $4 Price Target	22-12-29	MT
B. Riley Lowers Augmedix's Price Target to $4.50 from $6.50 Based on Lower 2023 Enterprise Value/Sales Multiple, Keeps Buy Rating	22-08-01	MT
Lake Street Initiates Augmedix at Buy with $6 Price Target	22-03-07	MT
Maxim Starts Augmedix at Buy with $6 Price Target	22-01-21	MT
Maxim Starts Augmedix at Buy With $6 Price Target	22-01-21	MT
William Blair Initiates Coverage on Augmedix With Outperform Rating	21-11-01	MT
Benchmark Starts Augmedix at Buy With $6 Price Target	21-11-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Augmedix, Inc.

Equities

AUGX

US05105P1075

Analyst Reco.

Filters